COVID-19 Monoclonal Antibody Treatments: Using Evolving Evidence to Improve Care in the Pandemic

COVID-19 mAbs: Using Evolving Evidence Cover

White Paper

COVID-19 Monoclonal Antibody Treatments: Using Evolving Evidence to Improve Care in the Pandemic

Published date

January 27, 2021

Duke-Margolis Affiliated Authors

Morgan Romine headshot

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty